Q32 Bio
QTTB
QTTB
120 hedge funds and large institutions have $123M invested in Q32 Bio in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 41 increasing their positions, 30 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.17% more ownership
Funds ownership: 3.12% → 3.29% (+0.17%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
51% less capital invested
Capital invested by funds: $252M → $123M (-$129M)
Holders
120
Holding in Top 10
1
Calls
$793K
Puts
$369K
Top Buyers
| 1 | +$3.52M | |
| 2 | +$1.45M | |
| 3 | +$681K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$641K |
| 5 |
Renaissance Technologies
New York
|
+$531K |
Top Sellers
| 1 | -$1.34M | |
| 2 | -$713K | |
| 3 | -$634K | |
| 4 |
D.E. Shaw & Co
New York
|
-$589K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$523K |